Previous 10 |
OLDWICK, N.J. , April 2, 2019 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced the appointment of Douglas Jacobstein , M.D., as Vice President of Clinica...
OLDWICK, N.J. , March 28, 2019 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced the appointment of Jeffrey Bluestone, PhD, to the Company's Board of Directors....
Provention Bio, Inc. (PRVB) Q4 2018 Earnings Conference Call March 19, 2019 4:30 AM ET Company Participants Jason Rando – Investor Relations Ashleigh Palmer – Co-Founder and Chief Executive Officer Andrew Drechsler – Chief Financial Officer Francisco Leon &...
Provention Bio (NASDAQ: PRVB ): Q4 GAAP EPS of -$0.15 beats by $0.04 . More news on: Provention Bio, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
OLDWICK, N.J. , March 19, 2019 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today reported financial results for the fourth quarter and full year ended December 31, ...
OLDWICK, N.J. , March 12, 2019 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq:PRVB), a clinical-stage biopharmaceutical company focused on preventing and intercepting immune-mediated diseases, announced today it will host a conference call and live audio webcast on Tuesday, March 19, 2019 ...
OLDWICK, N.J. , Feb. 13, 2019 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical-stage biopharmaceutical company dedicated to developing novel therapeutics aimed at intercepting and preventing immune-mediated diseases, announced today its Chief Executive Officer, Ash...
OLDWICK, N.J. , Jan. 28, 2019 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq:PRVB), a clinical-stage biopharmaceutical company dedicated to developing novel therapeutics aimed at intercepting and preventing immune-mediated diseases, announced today that it has received a Notice of Allo...
News, Short Squeeze, Breakout and More Instantly...
Provention Bio, Inc. (NASDAQ: PRVB) has caught the attention of the investment community today with its bullish price action. The company's shares are currently up 3.14% on the day to $24.99. Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and comme...
2023-04-06 11:29:16 ET What Are Penny Stocks? The market for penny stocks has continued growing over the last few years. But what are these stocks in the first place? The general definition of penny stocks includes shares of companies trading below $5. Making money with penny st...
NEW YORK, NY / ACCESSWIRE / March 23, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Seagen Inc. (NASDAQ:SGEN)'s sale t...